BioNTech SE (BNTX) Total Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Liabilities data on file, last reported at $3.2 billion in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities fell 3.44% year-over-year to $3.2 billion; the trailing twelve-month figure through Dec 2025 stood at $3.2 billion (down 3.44% YoY), and the FY2025 full-year result was $3.1 billion, down 6.28% from the prior year.
• Total Liabilities slipped to $3.2 billion in Q4 2025, from $3.3 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $6.5 billion in Q3 2021 to a low of $7.0 million in Q4 2021.
• A 5-year average of $3.3 billion and a median of $3.3 billion in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities slumped 99.38% in 2021 and surged 47029.01% in 2022, its largest moves.
• Tracing BNTX's Total Liabilities over 5 years: stood at $7.0 million in 2021, then surged by 47029.01% to $3.3 billion in 2022, then slipped by 9.69% to $3.0 billion in 2023, then grew by 12.21% to $3.3 billion in 2024, then fell by 3.44% to $3.2 billion in 2025.
• Business Quant data shows BNTX's Total Liabilities at $3.2 billion in Q4 2025, $3.3 billion in Q3 2025, and $3.5 billion in Q2 2025.